New Zealand markets closed

Medtronic plc (MDT)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
88.26+0.49 (+0.56%)
At close: 04:00PM EDT
87.50 -0.76 (-0.86%)
After hours: 07:51PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 113.20B
Enterprise value 133.22B
Trailing P/E 29.72
Forward P/E 16.18
PEG ratio (5-yr expected) 1.63
Price/sales (ttm)3.58
Price/book (mrq)2.36
Enterprise value/revenue 4.09
Enterprise value/EBITDA 16.08

Trading information

Stock price history

Beta (5Y monthly) 0.85
52-week change 317.48%
S&P500 52-week change 332.65%
52-week high 391.49
52-week low 368.84
50-day moving average 386.58
200-day moving average 383.83

Share statistics

Avg vol (3-month) 36.46M
Avg vol (10-day) 35.06M
Shares outstanding 51.28B
Implied shares outstanding 61.3B
Float 81.28B
% held by insiders 10.26%
% held by institutions 185.93%
Shares short (13 Sept 2024) 412.7M
Short ratio (13 Sept 2024) 41.95
Short % of float (13 Sept 2024) 40.99%
Short % of shares outstanding (13 Sept 2024) 40.99%
Shares short (prior month 15 Aug 2024) 414.84M

Dividends & splits

Forward annual dividend rate 42.8
Forward annual dividend yield 43.17%
Trailing annual dividend rate 32.77
Trailing annual dividend yield 33.16%
5-year average dividend yield 42.63
Payout ratio 493.27%
Dividend date 311 Oct 2024
Ex-dividend date 427 Sept 2024
Last split factor 22:1
Last split date 327 Sept 1999

Financial highlights

Fiscal year

Fiscal year ends 26 Apr 2024
Most-recent quarter (mrq)26 Jul 2024

Profitability

Profit margin 12.06%
Operating margin (ttm)17.51%

Management effectiveness

Return on assets (ttm)4.41%
Return on equity (ttm)7.95%

Income statement

Revenue (ttm)32.58B
Revenue per share (ttm)24.71
Quarterly revenue growth (yoy)2.80%
Gross profit (ttm)N/A
EBITDA 9.01B
Net income avi to common (ttm)3.93B
Diluted EPS (ttm)2.97
Quarterly earnings growth (yoy)31.70%

Balance sheet

Total cash (mrq)7.84B
Total cash per share (mrq)6.11
Total debt (mrq)27.86B
Total debt/equity (mrq)57.86%
Current ratio (mrq)2.13
Book value per share (mrq)37.39

Cash flow statement

Operating cash flow (ttm)6.9B
Levered free cash flow (ttm)4.9B